Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

NCT01368536 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
975
Enrollment
INDUSTRY
Sponsor class

Stopped Based on results from an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals